» Articles » PMID: 33718216

Continuous Renal Replacement Therapy: A Review of Use and Application in Pediatric Hematopoietic Stem Cell Transplant Recipients

Overview
Journal Front Oncol
Specialty Oncology
Date 2021 Mar 15
PMID 33718216
Citations 6
Authors
Affiliations
Soon will be listed here.
Abstract

Hematopoietic stem cell transplant (HSCT) is a curative therapy for malignant and non-malignant conditions. However, complications post-HSCT contribute to significant morbidity and mortality in this population. Acute kidney injury (AKI) is common in the post-allogeneic transplant phase and contributes to morbidity in this population. Continuous renal replacement therapy (CRRT) is used often in the setting of AKI or multiorgan dysfunction in critically ill children. In addition, CRRT can be useful in many disease processes related to transplant and can potentially improve outcomes in this population. This review will focus on the use of CRRT in critically ill children in the post-HSCT setting outside the realm of acute renal failure and highlight the benefits and applications of this modality in this high-risk population.

Citing Articles

Editorial: Critical complications in pediatric oncology and hematopoietic cell transplant, volume II.

McArthur J, Mahadeo K, Agulnik A, Steiner M Front Oncol. 2024; 14:1512659.

PMID: 39555452 PMC: 11564162. DOI: 10.3389/fonc.2024.1512659.


Fluid Overload in Children Following Hematopoietic Cell Transplant: A Comprehensive Review.

Elbahlawan L, Qudeimat A, Morrison R, Schaller A J Clin Med. 2024; 13(21).

PMID: 39518488 PMC: 11546381. DOI: 10.3390/jcm13216348.


Clinical characteristics and mortality risk factors of mixed bacterial infections in hematopoietic stem cell transplantation recipients.

Liu Y, Liu Y, Chen X, Jia Y Front Cell Infect Microbiol. 2023; 13:1223824.

PMID: 37790911 PMC: 10543755. DOI: 10.3389/fcimb.2023.1223824.


Kidney Injury in Children after Hematopoietic Stem Cell Transplant.

James V, Angelo J, Elbahlawan L Curr Oncol. 2023; 30(3):3329-3343.

PMID: 36975466 PMC: 10047595. DOI: 10.3390/curroncol30030253.


Acute kidney injury in pediatric hematopoietic cell transplantation: critical appraisal and consensus.

Raina R, Abu-Arja R, Sethi S, Dua R, Chakraborty R, Dibb J Pediatr Nephrol. 2022; 37(6):1179-1203.

PMID: 35224659 DOI: 10.1007/s00467-022-05448-x.


References
1.
Rondon G, Saliba R, Chen J, Ledesma C, Alousi A, Oran B . Impact of Fluid Overload as New Toxicity Category on Hematopoietic Stem Cell Transplantation Outcomes. Biol Blood Marrow Transplant. 2017; 23(12):2166-2171. PMC: 5889108. DOI: 10.1016/j.bbmt.2017.08.021. View

2.
Raymakers-Janssen P, Lilien M, Tibboel D, Kneyber M, Dijkstra S, van Woensel J . Epidemiology and Outcome of Critically Ill Pediatric Cancer and Hematopoietic Stem Cell Transplant Patients Requiring Continuous Renal Replacement Therapy: A Retrospective Nationwide Cohort Study. Crit Care Med. 2019; 47(11):e893-e901. PMC: 6798750. DOI: 10.1097/CCM.0000000000003973. View

3.
Khwaja A . KDIGO clinical practice guidelines for acute kidney injury. Nephron Clin Pract. 2012; 120(4):c179-84. DOI: 10.1159/000339789. View

4.
Fayad A, Buamscha D, Ciapponi A . Intensity of continuous renal replacement therapy for acute kidney injury. Cochrane Database Syst Rev. 2016; 10:CD010613. PMC: 6457961. DOI: 10.1002/14651858.CD010613.pub2. View

5.
Warrillow S, Fisher C, Tibballs H, Bailey M, McArthur C, Lawson-Smith P . Continuous renal replacement therapy and its impact on hyperammonaemia in acute liver failure. Crit Care Resusc. 2020; 22(2):158-165. PMC: 10692487. View